Your browser doesn't support javascript.
loading
Recombinant Apyrase (AZD3366) Against Myocardial Reperfusion Injury.
Birnbaum, Yochai; Ye, Regina; Chen, Huan; Carlsson, Leif; Whatling, Carl; Fjellström, Ola; Ryberg, Erik; Ye, Yumei.
Afiliação
  • Birnbaum Y; The Section of Cardiology, Department of Medicine, Baylor College of Medicine, 7200 Cambridge Street, Houston, TX, 77030, USA. ybirnbau@bcm.edu.
  • Ye R; University of Texas at Austin, Austin, TX, USA.
  • Chen H; Department of Acupuncture, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Carlsson L; The Department of Biochemistry and Molecular Biology, Medical Branch, University of Texas, 301 University Blvd, BSB 648, Galveston, TX, 77555, USA.
  • Whatling C; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Fjellström O; Translational Sciences and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ryberg E; Projects, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ye Y; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Cardiovasc Drugs Ther ; 37(4): 625-646, 2023 08.
Article em En | MEDLINE | ID: mdl-35192075

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão Miocárdica Limite: Animals Idioma: En Revista: Cardiovasc Drugs Ther Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão Miocárdica Limite: Animals Idioma: En Revista: Cardiovasc Drugs Ther Ano de publicação: 2023 Tipo de documento: Article